Loading clinical trials...
Loading clinical trials...
The Elizabeth Registry for Low Grade Ovarian Cancer
Long-Term Objectives: * To establish an ongoing national research registry of epidemiologic, clinical and pathologic data on low grade and low malignant potential (LMP) ovarian cancer patients in UTMDACC's Department of Gynecologic Oncology for research purposes. * To create a bank of low grade and LMP ovarian cancer tumor blocks for study of the molecular and histopathologic differences among low grade ovarian cancer, ovarian LMP tumors and high grade ovarian cancer. * To specify the epidemiologic and clinical profile of low grade and LMP ovarian cancer patients. * To identify potential precursors of low grade and LMP ovarian cancer. * To assess treatment patterns to guide management of these diseases. * To collect quality of life and health outcomes data on these patients. * To achieve a fundamental understanding of low grade and LMP ovarian cancer that will inform prevention and screening efforts, motivate development of improved treatments and eventually result in a cure. The short-term objectives are: * To detail procedures for potential registrant identification and recruitment. * To create a demographic and health history questionnaire for potential registrants. * To begin aggregating low grade and low malignant potential ovarian tumor blocks. * To specify a timeline for the development of all other aspects of the Registry.
The Registry will be an ongoing research registry that will include patients who have been diagnosed with low grade ovarian, primary peritoneal or fallopian tube or low malignant potential (LMP) ovarian, primary peritoneal or fallopian tube cancer. In order to enroll in the Registry, you will be asked to complete a 65 page questionnaire that contains questions about your ovarian cancer diagnosis, gynecologic history, family history, general medical history, and health risk factors. This questionnaire will take about 1 hour to complete. In addition, researchers will look at your medical record and pathology samples stored at M. D. Anderson to get information about your surgeries, treatments, disease course, and tumor grade. If your original surgery was not performed at M. D. Anderson, you may be asked to provide tumor specimens from that surgery before enrolling in the Registry. You will be contacted annually by the Registry Coordinator to update your demographic and health information. This is an investigational study. The Registry will eventually enroll both M. D. Anderson and non-M. D. Anderson patients. The number of registrants is unlimited because the Registry will be ongoing. This study is partially funded by a research grant from the Elizabeth Fund for the Study of Low Grade Ovarian Carcinoma.
Age
All ages
Sex
FEMALE
Healthy Volunteers
No
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Start Date
September 1, 2003
Primary Completion Date
October 1, 2014
Completion Date
October 1, 2014
Last Updated
October 7, 2015
60
ACTUAL participants
Questionnaire
BEHAVIORAL
Lead Sponsor
M.D. Anderson Cancer Center
NCT05039801
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions